Systematic Discovery and Validation of T Cell Targets Directed against Oncogenic KRAS Mutations

The authors evaluated the presentation of mutant KRAS peptides on individual HLA-I molecules using targeted mass spectrometry and identify 13 unpublished KRASG12C/D/R/V mutation/HLA-I pairs and nine previously described pairs.